Gene · 11065
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma. | J Cell Mol Med | 2023 | 37246638 | PubTator, text mining | PubMed |
| Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. | Signal Transduct Target Ther | 2023 | 37244925 | PubTator, text mining | PubMed |
| Gene Expression Profiling of Fibroepithelial Lesions of the Breast. | Int J Mol Sci | 2023 | 37240386 | PubTator, text mining | PubMed |
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations. | Breast Cancer Res | 2023 | 37231433 | PubTator, text mining | PubMed |
| A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencing. | BMC Bioinformatics | 2023 | 37231356 | PubTator, text mining | PubMed |
| The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response. | Genes Dis | 2023 | 37223535 | PubTator, text mining | PubMed |
| The role of regulators of RNA m6A methylation in lung cancer. | Genes Dis | 2023 | 37223516 | PubTator, text mining | PubMed |
| UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease. | Neurooncol Adv | 2023 | 37215954 | PubTator, text mining | PubMed |
| Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma. | Dis Markers | 2023 | 37215201 | PubTator, text mining | PubMed |
| HEY1-NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice. | JCI Insight | 2023 | 37212282 | PubTator, text mining | PubMed |
| Lactate fuels mitosis. | Mol Cell | 2023 | 37207623 | PubTator, text mining | PubMed |
| A prediction model identifying glycolysis signature as therapeutic target for psoriasis. | Front Immunol | 2023 | 37205116 | PubTator, text mining | PubMed |
| The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response. | Front Oncol | 2023 | 37197417 | PubTator, text mining | PubMed |
| The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy. | Cancers (Basel) | 2023 | 37190151 | PubTator, text mining | PubMed |
| Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. | Cell Commun Signal | 2023 | 37189112 | PubTator, text mining | PubMed |
| [Progress in the Study of Spindle Assembly Checkpoint in Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2023 | 37183646 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals Conserved Regulatory Networks in Human and Mouse Interneuron Development. | Int J Mol Sci | 2023 | 37175835 | PubTator, text mining | PubMed |
| Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma. | Pathol Oncol Res | 2023 | 37168048 | PubTator, text mining | PubMed |
| Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer. | Cancer Commun (Lond) | 2023 | 37158690 | PubTator, text mining | PubMed |
| TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer. | Proc Natl Acad Sci U S A | 2023 | 37155905 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11065/papers?page=19